BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6437863)

  • 1. [Cytotoxic action of thiophosphamide on human tumor cells].
    Korman DB; Krutova TV; Shamaev VI
    Farmakol Toksikol; 1984; 47(5):70-4. PubMed ID: 6437863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of thiophosphamide on the proliferative activity of human tumor cells cultured in vivo in diffusion chambers.
    Korman DB; Krutova TV; Shamajev VI
    Arch Geschwulstforsch; 1984; 54(2):105-11. PubMed ID: 6428373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the proliferative activity of human breast cancer cells cultivated in vivo in diffusion chambers in response to antineoplastic agents].
    Shamaev VI; Krutova TV; D'iachkovskaia RF; Korman DB
    Biull Eksp Biol Med; 1981 Jul; 92(7):77-9. PubMed ID: 6794665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo tumor growth inhibition produced by a novel sulfonamide, E7010, against rodent and human tumors.
    Koyanagi N; Nagasu T; Fujita F; Watanabe T; Tsukahara K; Funahashi Y; Fujita M; Taguchi T; Yoshino H; Kitoh K
    Cancer Res; 1994 Apr; 54(7):1702-6. PubMed ID: 8137285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor action of thiophosphamide against a background of glucose modification of the tumor cell mitotic cycle and a decrease in intratumor pH].
    Osinskii SP; Bubnovskaia LN
    Vopr Onkol; 1981; 27(2):51-5. PubMed ID: 6782757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of antitumor preparations on the cellular proliferation of human gastrointestinal tract tumors cultured in diffusion chambers in vivo].
    Korman DB; Krutova TV; Shamaev VI; D'iachkovskaia RF
    Izv Akad Nauk SSSR Biol; 1982; (5):773-8. PubMed ID: 6815250
    [No Abstract]   [Full Text] [Related]  

  • 7. The study of the cytotoxic effect of anticancer drugs on human lung tumors transplanted to mice by use of diffusion chambers.
    Korman DB; Krutova TV; Potapov YN; Pashkova VS
    Neoplasma; 1985; 32(2):169-75. PubMed ID: 2987711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of thiophosphamide, its paramagnetic analogs and the iminoxyl radical on the division of tumor cells].
    Kiseleva EG; Konovalova NP
    Vopr Onkol; 1978; 24(4):60-5. PubMed ID: 207020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.
    Sugano M; Egilmez NK; Yokota SJ; Chen FA; Harding J; Huang SK; Bankert RB
    Cancer Res; 2000 Dec; 60(24):6942-9. PubMed ID: 11156394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Selective action of hydrazine sulfate in combination with thiophosphamide on tumor cell mitochondria].
    Tret'iakov AV; Golovatova VA; Filov VA
    Vopr Onkol; 1982; 28(3):86-8. PubMed ID: 6461132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of anthracycline antibiotics on the cellular proliferation of human breast cancer heterografts growing in diffusion chambers in vivo].
    Batomunkueva TV; Korman DB; Krutova TV
    Izv Akad Nauk SSSR Biol; 1989; (2):184-90. PubMed ID: 2745857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effects of TZT-1027, a novel dolastatin 10 derivative, on human tumor xenografts in nude mice].
    Fujita F; Koike M; Fujita M; Sakamoto Y; Tsukagoshi S
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):451-8. PubMed ID: 10740640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative evaluation of the effectiveness of antitumor preparations in human lung cancer xenografts growing on mice in diffusion chambers].
    Krutova TV; Korman DB; Potapov IuN; Pashkova VS
    Izv Akad Nauk SSSR Biol; 1984; (6):901-8. PubMed ID: 6097608
    [No Abstract]   [Full Text] [Related]  

  • 14. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
    Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
    Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhanced proliferation of human lung cancer cells during culture in diffusion chambers].
    Krutova TV; Korman DB; Potapov IuN; Pashkova VS
    Vopr Onkol; 1984; 30(8):91-5. PubMed ID: 6091342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.
    Giuliani FC; Zirvi KA; Kaplan NO
    Cancer Res; 1981 Jan; 41(1):325-35. PubMed ID: 7448772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.
    Robertson FM; Mallery SR; Bergdall-Costell VK; Cheng M; Pei P; Prosperi JR; Ferrari M
    Anticancer Res; 2007; 27(2):719-27. PubMed ID: 17465194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
    Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth and metastasis of surgical specimens of human breast carcinomas in SCID mice.
    Sakakibara T; Xu Y; Bumpers HL; Chen FA; Bankert RB; Arredondo MA; Edge SB; Repasky EA
    Cancer J Sci Am; 1996; 2(5):291-300. PubMed ID: 9166547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
    Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
    Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.